Back to Journals » OncoTargets and Therapy » Volume 8

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]

Total article views   HTML views PDF downloads Totals
8,129 Dovepress* 7,757+ 1,565 9,322
PubMed Central* 372 136 508
Totals 8,129 1,701 9,830
*Since 9 March 2015
+Since July 2016

View citations on PubMed Central and Google Scholar